Skip to main navigation
Ascendis Pharma Logo
  • Overview
  • Events & Presentations
  • News Releases
    • For Global Media Only
    • For U.S. Media Only
  • Corporate Governance
    • Corporate Governance Documents & Charters
    • Leadership
    • Committee Composition
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
  • Financial & Filings
    • Quarterly Reports
    • SEC Filings
    • Annual General Meeting
    • Extraordinary General Meeting
      • Sept. 9, 2022 EGM
      • Nov. 18, 2021 EGM

Events & Presentations

Events & Presentations

Upcoming Events

More events are coming soon.

Past Events

January 09, 2023 at 12:00 PM EST
41st Annual J.P. Morgan Healthcare Conference
Click here for webcast link
41st Annual J.P. Morgan Healthcare Conference Presentation 3.5 MB

Presentations

January 8, 2023
41st Annual J.P. Morgan Healthcare Conference Presentation
November 13, 2022
TransCon™ CNP ACcomplisH Trial Topline Results
November 11, 2022
TransCon™ TLR7/8 Agonist Initial Results from Dose Escalation Portion of transcendIT-101 Trial
September 12, 2022
TransCon™ PTH Week 110 Phase 2 PaTH Forward Trial Presentation
March 13, 2022
Phase 3 PaTHway Trial top-line results
January 10, 2022
40th Annual J.P. Morgan Healthcare Conference Presentation
December 14, 2021
Virtual R&D Program Update
November 30, 2021
Investor Presentation
November 18, 2021
TransCon PTH PaTH Forward Trial Week 84 Top-Line Results
August 25, 2021
SKYTROFA® FDA Approval Slide Presentation

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »

Shareholder Tools

RSS Feeds
Email Alerts
IR Contact

Footer Corporate Menu

  • TransCon
  • About us
  • Pipeline
  • Patients
  • Investors & News
  • Contact Us

Footer Copyrights Menu

  • Privacy Policy
  • Terms of Use
Ascendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group
© January 2023 Ascendis Pharma